The Bangladeshi corporation final week received 5 million of the 30 million doses it had ordered from SII for Bangladesh’s immunisation programme that starts next week.
Beximco had separately ordered 1 million doses for sale on the private industry, with the hope to begin promoting it this month.
Also Read: China Bat Caves Need Exploring To Trace Covid Origins: WHO Team Member
“However, the company has now been informed by SII that the first instalment (500,000 doses) of this supply will be delayed following a prioritisation on supplying vaccine doses for government mass vaccination programmes and WHO-led COVAX initiatives over private pay use,” Beximco mentioned in a regulatory filing.
“It remains unclear how long this delay will last.”
Beximco’s chief operating officer told Reuters final month the corporation could get up to 3 million doses of the vaccine from SII at about $8 each and every for sale on the private industry.
Also Read: Farmers’ protest: Delhi Police registers FIR against climate activist Greta Thunberg
The value is about twice the $4 per dose that Beximco had agreed for the government programme.
AstraZeneca has been embroiled in a dispute in Europe soon after it mentioned it would have to reduce supplies of its vaccine there in the 1st quarter
The WHO has known as for vaccines to be really should be shared equitably and has urged nations them not to jostle for deliveries.